Загрузка...
Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma
Next-generation sequencing (NGS) has been applied to monitor minimal residual disease (MRD) in multiple myeloma (MM). Standardized DNA input and sequencing depth is essential for achieving a uniform sensitivity in NGS-based MRD study. Herein, the sensitivity of 10(−5) was verified by a standardized...
Сохранить в:
| Опубликовано в: : | Front Oncol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6563351/ https://ncbi.nlm.nih.gov/pubmed/31245284 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00449 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|